Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 14, Issue 5, pp. 470-481
PubMed
Published By
Print ISSN
Online ISSN
History
- Received February 12, 2016
- Accepted February 20, 2016
- Published first March 10, 2016.
Article Versions
- Previous version (March 10, 2016 - 06:42).
- Previous version (May 4, 2016 - 11:53).
- You are viewing the most recent version of this article.
Copyright & Usage
©2016 American Association for Cancer Research.
Author Information
- Luca Malorni1,2,3,*,
- Mario Giuliano1,2,4,
- Ilenia Migliaccio3,
- Tao Wang1,
- Chad J. Creighton1,2,
- Mathieu Lupien5,
- Xiaoyong Fu1,2,
- Susan G. Hilsenbeck1,2,
- Nuala Healy6,
- Carmine De Angelis1,2,4,
- Abhijit Mazumdar7,
- Meghana V. Trivedi1,2,8,
- Suleiman Massarweh9,
- Carolina Gutierrez1,10,
- Sabino De Placido4,
- Rinath Jeselsohn11,12,
- Myles Brown11,12,
- Powel H. Brown7,
- C. Kent Osborne1,2,13, and
- Rachel Schiff1,2,13,*
- 1Lester and Sue Smith Breast Center and Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.
- 2Department of Medicine, Baylor College of Medicine, Houston, Texas.
- 3Sandro Pitigliani Medical Oncology Unit and Translational Research Unit, Oncology Department, Hospital of Prato, Prato, Italy.
- 4Department of Clinical Medicine and Surgery, Oncology Division, University of Naples Federico II, Naples, Italy.
- 5Ontario Cancer Institute, Princess Margaret Cancer Center-University Health Network, Ontario Institute for Cancer Research and the Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
- 6Department of Radiology, St. James's Hospital, Dublin, Ireland.
- 7Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas.
- 8Department of Clinical Sciences and Administration, University of Houston College of Pharmacy, Houston, Texas.
- 9Department of Medicine and Stanford Cancer Institute, Stanford University, Stanford, California.
- 10Department of Pathology, Baylor College of Medicine, Houston, Texas.
- 11Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
- 12Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.
- 13Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas.
- ↵*Corresponding Authors:
Rachel Schiff, Baylor College of Medicine, 1 Baylor Plaza, Alkek Buld. N1230, Houston, TX 77030. Phone: 713-798-1676; Fax: 713-798-1659; E-mail: rschiff{at}bcm.edu; and Luca Malorni, Hospital of Prato, Sandro Pitigliani Medical Oncology Unit and Translational Research Unit, Via Suor Niccolina 20, Prato 59100, Italy. Phone: +39 0574 802523; Fax: +39 0574 802903; E-mail: lmalorni{at}uslcentro.toscana.it
May 2016
Volume 14, Issue 5
Volume 14, Issue 5
Blockade of AP-1 Potentiates Endocrine Therapy and Overcomes Resistance
Jump to section
Advertisement